The Virtual Cancer Caregivers Education Programs, VCCEP® address the challenges faced by cancer caregivers. Delivered online, the VCCEP includes a ‘learning center’ that integrates 15 years of successful cancer caregiver workshops and training, including knowledge and perspectives from cancer patients, cancer caregivers and cancer care professionals.Continue reading
Category Archives: AZBio News
AZBio to Honor Ten Arizona Legislators as Trailblazers in 2022
The 2022 AZBio Trailblazer Honorees are: Senator Nancy Barto, Senator Sonny Borrelli, Senator Sean Bowie, Senator David Gowan, Senator Sine Kerr, Senator T.J. Shope, Representative Regina Cobb, DDS , Representative Daniel Hernandez, Jr., Representative Amish Shah, MD, and Representative Justin Wilmeth.Continue reading
C-Path’s Transplant Therapeutics Consortium Receives EMA Draft Qualification Opinion for iBox Scoring System
The draft EMA qualification opinion is available for public consultation until November 17, 2022
Secondary endpoint prognostic for allograft loss to catalyze development of novel therapies intended to improve long-term outcomes for kidney transplant recipientsContinue reading
The Mayo Clinic and Arizona State University Pitch Competition
The Mayo Clinic and Arizona State University Alliance jointly launched the Scorpion Tank, a healthcare pitch competition.Continue reading
Vidium Animal HealthⓇ and Torigen Pharmaceuticals Partner to Increase Accessibility of Advanced Cancer Care for Canine Patients
PHOENIX—October 11, 2022—Vidium Animal Health announced today that it has partnered with Torigen Pharmaceuticals, an animal health biologics company, to offer genomic testing and precision medicine to more veterinarians. By opening up the use of personalized, precision medicine to the veterinary marketplace, Vidium and Torigen are providing specialists and general practicing veterinarians with more options to advance the care of dogs with cancer.Continue reading
BIO Announces Appointment of Interim CEO
The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. Michelle McMurry-Heath stepping down as President and CEO to serve as an Advisor to the Executive Committee of the BIO Board of Directors. The organization is searching for a full-time successor.Continue reading
ASU professor to study new genome editing tools with NIH Innovator Award
There are many human genetic diseases — for example, sickle-cell disease, cystic fibrosis and Hutchinson-Gilford progeria syndrome — that currently have no cure and are caused by point mutations, for which there is a pressing need to develop precision genome editing tools able to correct these mutations with high efficiency and accuracy.
Assistant Professor Audrey Lapinaite from Arizona State University’s School of Molecular Sciences and the Biodesign Institute’s ASU-Banner Neurodegenerative Disease Research Center is working on this problem and has just been awarded a prestigious National Institutes of Health (NIH) Director’s New Innovator Award.Continue reading